Biotech

Marina Biotech Monetizes UNA Intellectual Property Estate Through Agreement With Arcturus Therapeutics

CAMBRIDGE, MA: ...

ProMetic to Develop and Commercialize Alpha1-Antitrypsin as Second Plasma-Derived Orphan Drug Product

LAVAL, QUEBEC: - ProMetic's process (PPPS(TM)) confirmed to produce Alpha1-Antitrypsin (AAT) with three-fold yield advantage over existing industry average - AAT to be manufactured in ProMetic's Laval faci ...

Mincom Capital Inc. Terminates Letter of Intent With Group Nanoxplore Inc.

OTTAWA, ONTARIO: ...

Ceapro Announces Signing of Growing Forward 2 Agreement

EDMONTON, ALBERTA: ...

Paladin Announces Passing of Founding Chairman, Ted Wise

MONTREAL, CANADA: ...

John Mon, COO of Medifocus, Inc., Is Featured in an Audio Interview on Princeton Research's Money Info Show Hosted by Bill Chippas and Charles Moskowitz

COLUMBIA, MD and TORONTO: Initiates On-Going Effort to Increase Investor Awareness ...

Cellceutix Clinical Study on Its Anti-Psoriasis Drug Prurisol(TM) to Commence

BEVERLY, MA: Company Beginning Process to Move to National Securities Exchange ...

Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry Date

AURORA, ON: ...

Adamis Pharmaceuticals Announces Investor Update Conference Call

SAN DIEGO, CA: ...

Stem Cell Therapeutics Acquires an Exclusive Option to License Prostate Cancer Stem Cell Assets

TORONTO, ONTARIO: Collaboration with Internationally Renowned Prostate Cancer Research Group ...